Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03900468 · ClinicalTrials.gov registry record · NA
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
A NA study of Epilepsy, sponsored by MedtronicNeuro.
- Active
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 13
- Study locations
NCT03900468: Active NA study of Epilepsy, sponsored by MedtronicNeuro.
NCT03900468 is a NA study of Epilepsy that is active but no longer recruiting, run by MedtronicNeuro. The registered enrollment target is 140 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (85% lower). The trial reports 13 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03900468, a NA study of Epilepsy, is active but no longer recruiting, sponsored by MedtronicNeuro.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
Primary Outcome
The percentage of total seizure frequency reduction will be assessed using the participant seizure diaries to demonstrate DBS therapy effectiveness
Conditions Studied
Interventions
- DEVICE Activa™ PC and Percept™ PC Neurostimulation Systems
Study Locations (13)
California
- University of California Los Angeles (UCLA) - Los Angeles
- University of California San Francisco UCSF Medical Center - San Francisco
- Stanford Hospital & Clinics - Stanford
Ohio
- Cleveland Clinic - Cleveland
- The Ohio State University - Columbus
Georgia
- Emory University Hospital - Atlanta
Illinois
- Rush University Medical Center - Chicago
Indiana
- Indiana University Health Neuroscience Center - Indianapolis
Kansas
- University of Kansas Medical Center - Kansas City
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic (Rochester MN) - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-03-05 |
| Est. Completion | 2026-03-27 |
| Phase | NA |
What the registry record for NCT03900468 still lists
NCT03900468 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Activa™ PC and Percept™ PC Neurostimulation Systems is the first listed.
NCT03900468 lists 13 locations in 10 states (California, Ohio, Georgia).
Frequently Asked Questions
What is clinical trial NCT03900468 about?
NCT03900468 is a clinical study titled "Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)". The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
What is the current status of trial NCT03900468?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2020-03-05. Estimated completion is 2026-03-27.
What conditions does trial NCT03900468 study?
This clinical trial studies the following conditions: Epilepsy.
What interventions are being tested in trial NCT03900468?
The interventions under investigation include: Activa™ PC and Percept™ PC Neurostimulation Systems (DEVICE).
Who is sponsoring clinical trial NCT03900468?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03900468 being conducted?
This trial has 13 study locations across California, Georgia, Illinois, Indiana, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03900468's enrollment target sits among peer trials
140 43rd of 160 higher than 118 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI